Belite Bio (BLTE) Non-Current Assets (2021 - 2025)

Belite Bio has reported Non-Current Assets for 5 years, with the latest figure at $286.3 million in Q4 2025.

• For the quarter ending Q4 2025, Non-Current Assets rose 5558.9% year-over-year to $286.3 million; the trailing twelve-month figure through Dec 2025 stood at $286.3 million (up 5558.9% YoY), and the FY2025 full-year result was $286.3 million, up 5558.9% from the prior year.
• Non-Current Assets for Q4 2025 stood at $286.3 million, up from $5.1 million in the prior quarter.
• The five-year high for Non-Current Assets was $286.3 million in Q4 2025, with the low at $917000.0 in Q4 2021.
• Average Non-Current Assets over 5 years is $59.7 million, with a median of $4.7 million recorded in 2023.
• Year-over-year, Non-Current Assets climbed 7.59% in 2024 and soared 5558.9% in 2025.
• Tracing BLTE's Non-Current Assets over 5 years: stood at $917000.0 in 2021, then surged by 59.87% to $1.5 million in 2022, then surged by 220.74% to $4.7 million in 2023, then increased by 7.59% to $5.1 million in 2024, then soared by 5558.9% to $286.3 million in 2025.
• The last three Non-Current Assets figures came in at $286.3 million (Q4 2025), $5.1 million (Q4 2024), and $4.7 million (Q4 2023), per Business Quant data.

Peer Comparison